PCRX icon

Pacira BioSciences
PCRX

Overview Fund Activity

231 hedge funds and large institutions have $2.06B invested in Pacira BioSciences in 2019 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 65 increasing their positions, 73 reducing their positions, and 30 closing their positions.

Holders
231
Holders Change
+20
Holders Change %
+9.48%
% of All Funds
4.56%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.08%
New
51
Increased
65
Reduced
73
Closed
30
Calls
$5.71M
Puts
$2.57M
Net Calls
+$3.15M
Net Calls Change
+$658K

Top Buyers

1
HM
1
HealthCor Management
New York
$34.9M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$81.4M
3
SCM
3
Spyglass Capital Management
California
$38.8M
4
Invesco
4
Invesco
Georgia
$27.6M
5
Macquarie Group
5
Macquarie Group
Australia
$93.9M

Top Sellers

1
ACA
1
Avoro Capital Advisors
New York
$0
2
Nuveen Asset Management
2
Nuveen Asset Management
Illinois
$22.1M
3
Millennium Management
3
Millennium Management
New York
$13M
4
FCM
4
Frontier Capital Management
Massachusetts
$61.1M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$1.39M
Name Holding Trade Value Shares
Change 		Shares
Change %
KC
251
Kepos Capital
New York
– -$173K -4,537 Closed
CAC
252
Cowen and Company
New York
– -$151K -3,979 Closed
TRCT
253
Tower Research Capital (TRC)
New York
– -$97K -2,551 Closed
PHK
254
Point72 Hong Kong
Hong Kong
– -$47K -1,239 Closed
Acadian Asset Management
255
Acadian Asset Management
Massachusetts
– -$9K -249 Closed
EW
256
Evoke Wealth
California
– -$8.64K -227 Closed
CFGS
257
Concourse Financial Group Securities
Alabama
– -$2K -47 Closed
JG
258
Jefferies Group
New York
– -$1K -35 Closed
Northwestern Mutual Wealth Management
259
Northwestern Mutual Wealth Management
Wisconsin
– -$1K -29 Closed
7 8 9 10
11